Latest Shareholder Engagement News

Paradigm Biopharmaceuticals reports solid progress in its Phase 3 knee osteoarthritis trial, expanding internationally and publishing key Phase 2 biomarker data. The company maintains a robust cash position to support ongoing clinical milestones.

Percheron Therapeutics has reported encouraging safety and efficacy signals from its HMBD-002 phase I trial, and outlined an innovative modular phase II trial design targeting multiple cancers in 2026.

MEC Resources has bolstered its stake in Advent Energy with a $1.55 million loan while navigating a pivotal Federal Court hearing on the PEP 11 Joint Venture. Meanwhile, progress on Clean Hydrogen Technology signals potential growth avenues.

Turners Automotive Group has issued over 180,000 new shares through its Dividend Reinvestment Plan and option exercises, subtly reshaping its capital structure as FY26 progresses.

BPH Energy’s December quarter report reveals significant progress in its investee projects amid ongoing legal challenges and strategic capital management. The company balances judicial reviews, regulatory milestones, and funding plans across energy and medical technology sectors.

New Murchison Gold Limited delivered a robust December quarter with production exceeding contractual ore sales limits and unveiled high-grade drilling success at the Lydia Gold Prospect, underpinning its growth ambitions.

WiseTech Global has announced its key financial and governance dates for FY26, highlighting its ongoing commitment to innovation and global logistics software dominance.

TerraCom Limited has successfully completed a $60 million entitlement offer, surpassing its initial $40 million underwriting and demonstrating strong support from substantial shareholders and management.

Ryzon Materials will exit the ASX as it pursues a US exchange listing and prepares a fresh capital raise. The company remains focused on advancing its Nachu Graphite Project despite the transition.

RocketBoots Limited has slightly increased its recent capital raising, issuing an additional 100,000 shares to raise a total of A$7.025 million, reinforcing its push into international markets.

Apiam Animal Health has secured Foreign Investment Review Board approval for its acquisition by Adamantem Capital, paving the way for a crucial shareholder vote in February.

Augustus Minerals has addressed ASX concerns over its recent appointment and election of a new director, clarifying compliance with listing rules despite timing challenges.